Intended for healthcare professionals

Rapid response to:

News Extra [these Stories Appear Only On The Web]

Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial

BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7318.891 (Published 20 October 2001) Cite this as: BMJ 2001;323:891

Rapid Response:

Other Paths to Consider

There numerous other paths to consider when the thyroid gland assays
are normal and symptoms persist.

The first path recognizes the medical science, circa 1970, and tests
for the deficiency in triiodothyronine. As suggested earlier, there is
the rT3 test, which, according to Brady, finds post thyroid deficiencies
in either conversion to or reception of triiodothyronine (T3). This would
suggest a triiodothyronine replacement. Although these replacements have
been disparaged, they are approved and indicated by the US Food and Drug
Administration.

The other paths recognize that hormone effects are more like shotgun
blasts than rifle shots. Per Thierry Hertoghe's book, most hormones
effect most everything to some degree. Thus, fatigue can be created by a
deficiency in any of several hormones...

However, and unfortunately, the hypothyroidism niche would rather
declare the patient is dreaming up her misery than to recognize these
potentials. Consequently, there is the overabundant and improper use of
"functional somatoform disorders" and "nonspecific symptoms." These
simply produced continued suffering from a chronic deficiency.

It would be quite beneficial if the hypothryoidism niche would lose
its innocence of medical ethics, make the patient the first concern, keep
up with medical science, etc.

Competing interests:
None declared

Competing interests: No competing interests

20 September 2008
Eric K Pritchard
Thinker
Self, 290 Pritchard Lane, Berkeley Springs, WV 25411